Novo Nordisk A/S

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure the diseases we treat. Novo Nordisk employs more than 45,000 people in 80 countries and markets its products in 169 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn and YouTube.

Role within Screen4Care

For the Screen4Care project, Novo Nordisk will be providing expertise and support in medical knowledge, data science and sources, publications and communications, and patient and public affairs within the rare diseases. Novo Nordisk will provide outreach support within their networks and to the relevant external professional and patient societies/organisations in garnering stakeholder feedback for the initiative. In addition, Novo Nordisk will sponsor 2 PhD students for analytical support to the project.